Bibliography
Found 16 results
Filters: Author is Berman, Joan W [Clear All Filters]
CCR2 on Peripheral Blood CD14CD16 Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?. J Neuroimmune Pharmacol. 2019 ;14(1):120-133.
CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?. Journal of Neuroimmune Pharmacology [Internet]. 2018 ;14. Available from: https://doi.org/10.1007/s11481-018-9792-7
CXCR7 mediates CD14+CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. Journal of Leukocyte Biology [Internet]. 2017 ;102. Available from: DOI: 10.1189/jlb.3HI0517-167R
. Dopamine Increases CD14CD16 Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis. J Neuroimmune Pharmacol [Internet]. 2017 ;12(2):353-370. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28133717
. Frontline Science: CXCR7 mediates CD14CD16 monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. J Leukoc Biol. 2017 ;102(5):1173-1185.
. HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS. J Neuroinflammation. 2016 ;13(1):54.
. Dopamine Increases CD14+CD16+ Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis. PLOS ONEPLOS ONE [Internet]. 2015 ;10(2):e0117450 - . Available from: https://doi.org/10.1371/journal.pone.0117450
. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol [Internet]. 2015 ;97(2):401-12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25420915
. CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders. Neurol Neuroimmunol Neuroinflamm [Internet]. 2014 ;1(3):e36. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25340088
. Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders. Curr HIV Res. 2014 ;12(2):85-96.
. HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism. Journal of Neurochemistry [Internet]. 2013 ;128(5):752-763. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24134157
. Mechanisms of HIV Entry Into the CNS: Increased Sensitivity of HIV Infected CD14+CD16+ Monocytes to CCL2 and Key Roles of CCR2, JAM-A, and ALCAM in Diapedesis. PLoS ONE [Internet]. 2013 ;8(7). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23922698
. Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND. Journal of NeuroImmune Pharmacology [Internet]. 2013 ;8(5):1159-1166. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23616272
. Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesis. The American Journal of Pathology [Internet]. 2010 ;176:2819-2830. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20448061
. PrPC, the Cellular Isoform of the Human Prion Protein, Is a Novel Biomarker of HIV-Associated Neurocognitive Impairment and Mediates Neuroinflammation. The American Journal of Pathology [Internet]. 2010 ;177(4):1848-60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20724601
. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. The American Journal of Pathology [Internet]. 2008 ;172:1100-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18310503
.